Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
PYLARIFY TRUVU (PIFLUFOLASTAT F-18) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
PYLARIFY TRUVU
NDA
Get alerts
PIFLUFOLASTAT F-18 | N220089 | APHELION LLC
1 strength
6 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Label
Products
Patent Timeline
6 unique patents, 1 exclusivity by expiration date
Active (6)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
8487129
Nov. 7, 2027
8778305
Sep. 21, 2030
9861713
Jul. 31, 2029
10947197
Jun. 9, 2037
11851407
Jun. 9, 2037
12070513
Jul. 31, 2029
NCE
May. 26, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 1mCi/mL-120mCi/mL
RLD
6 patents
1 exclusivity
▴
SOLUTION;INTRAVENOUS | Approved: Mar 6, 2026
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8487129
Nov 7, 2027
—
Yes
Yes
—
—
8778305
Sep 21, 2030
—
Yes
Yes
U-3317
POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER
—
9861713
Jul 31, 2029
—
Yes
Yes
U-3317
POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER
—
10947197
Jun 9, 2037
—
Yes
Yes
U-3317
POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER
—
11851407
Jun 9, 2037
—
Yes
Yes
U-3317
POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER
—
12070513
Jul 31, 2029
—
Yes
Yes
U-3317
POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER
—
Exclusivities (1)
Code
Date
Status
NCE
May 26, 2026
Expired